Ministry of Health and Family WelfareHealthIndiaCOVID-19

COVID – 19 Vaccination Update – Day 407

India’s cumulative vaccination coverage over 177.40Crore. More than 21 lakh Vaccine doses administered today till 7 pm

India’s COVID-19 vaccination coverage hascrossed177.40 Crore (1,77,40,59,720) today. More than21lakh (21,41,821Vaccine Doseshave been administered till 7 pm today. More than1.99 Crore(1,99,62,729) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10401480
2nd Dose 9965907
Precaution Dose 4166909
FLWs 1st Dose 18409341
2nd Dose 17439847
Precaution Dose 6191330
Age Group 15-18 years 1st Dose 54747973
  2nd Dose 27260355
Age Group 18-44 years 1st Dose 551674510
2nd Dose 443457581
Age Group 45-59 years 1st Dose 202251597
2nd Dose 179982110
Over 60 years 1st Dose 126392536
2nd Dose 112113754
Precaution Dose 9604490
Cumulative 1st dose administered 963877437
Cumulative 2nd dose administered 790219554
Precaution Dose 19962729
Total 1774059720

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 26thFebruary, 2022 (407thDay)
HCWs 1st Dose 79
2nd Dose 1242
Precaution Dose 13104
FLWs 1st Dose 131
2nd Dose 2302
Precaution Dose 20887
Age Group 15-18 years 1st Dose 113130
  2nd Dose 606101
Age Group 18-44 years 1st Dose 142585
2nd Dose 853526
Age Group 45-59 years 1st Dose 20991
2nd Dose 178572
Over 60 years 1st Dose 18698
2nd Dose 108961
Precaution Dose 61512
Cumulative 1st dose administered 295614
Cumulative 2nd dose administered 1750704
Precaution Dose 95503
Total 2141821

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker